News Story: Full Text
Sponsored By
NovoCure Trial
Please Click On The Above Banner For More Details
Braintumor Website

 

Image-Guided Neurologics and Peregrine Pharmaceuticals Agree to Study Use Of Navigus(R) Array Catheter in Treatment of Brain Cancer (PR Newswire) Image-Guided Neurologics, a medical device company developing access and navigational products for minimally invasive neurosurgery techniques, and Peregrine Pharmaceuticals, Inc., have agreed to co-sponsor a Phase I/II pilot study for Cotara(TM), Peregrine`s Tumor Necrosis Therapy drug, that utilizes IGN`s Navigus(R) Array multi-lumen intracranial catheter in patients with brain cancer. - Aug 22 7:45 AM ET


IF the story does not appear below, Click HERE to view the text of the story!
Note: The original website is displayed below - we have no control over it and are not responsible for the content of it, we just report it! IF you click on anything below, it will take you off of our website!
Original Source: http://biz.yahoo.com/prnews/010822/mnw004_2.html


(Everything below this line is from VirtualTrials.com!)

Click HERE to return to brain tumor news headlines


Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2019 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740